Companies / BOC Sciences / Bectumomab
BOC Sciences

Bectumomab | BOC Sciences

Bectumomab is a monoclonal IgG2a antibody directed against CD22. Bectumomab has been used in the treatment of non-Hodgkin's lymphoma.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More